Xilio Therapeutics, Inc. (XLO) — Dilution Risk Analysis
Current Snapshot
Xilio Therapeutics, Inc. (XLO) has a DilutionWatch score of 37/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 37/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
2 shelf registration or ATM offering filings detected in recent history.
Recent filing forms in the source payload: 4 6, 424B5 2, 8-K 2.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-03-30 | 0001193125-26-131745 |
| 4 | 2026-02-17 | 0001123292-26-000187 |
| 424B5 | 2026-02-12 | 0001193125-26-048934 |
| 8-K | 2026-02-12 | 0001193125-26-048942 |
| 424B5 | 2026-02-11 | 0001193125-26-046842 |
| 8-K | 2026-01-05 | 0001193125-26-001580 |
| 4 | 2026-01-05 | 0001193125-26-002512 |
| 4 | 2026-01-05 | 0001193125-26-002517 |
| 4 | 2026-01-05 | 0001193125-26-002518 |
| 4 | 2026-01-05 | 0001193125-26-002520 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| ATM offering capacity remaining | $9,500,000 | Source |
| Cash runway | 56 months | Source |
| Three-year share count growth | 67.96% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 37/10) Source
- Cash Runway
- 56 months Source
- ATM Offering Capacity Remaining
- $9,500,000 Source
- Share Count Growth (3-Year)
- 67.96% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.